Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
05/2002
05/29/2002EP1209146A1 Process for the hydrogenation of nitriles to primary amines using Raney-catalysts
05/29/2002EP1208077A1 2-hydroxy-5-amino-biphenyl-derivatives and oxidative hair colouring agents containing said compounds
05/29/2002EP1207869A2 Antimycotic drug
05/29/2002EP1207868A1 Pharmaceutical tramadol salts
05/29/2002EP1207866A1 Delayed-action form of administration containing tramadol saccharinate
05/29/2002EP1207858A1 Oral dosage forms
05/29/2002EP0880496B1 Biphenyl compounds and use thereof as oestrogenic agents
05/29/2002CN1351615A Method of polymerization
05/29/2002CN1351583A Oxyalkylene-substituted aminophenol intermediate
05/28/2002US6395939 Catalytic etherification and condensation with copper catalysts
05/28/2002US6395919 Calcilytic compounds
05/28/2002US6395916 Amine, phosphine ligands
05/23/2002US20020061879 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
05/23/2002DE10056840A1 Continuous hydrogenation of nitrites to primary amines over activated Raney catalyst, involves hydrogenating nitrites in absence of ammonia and basic alkali or alkaline earth metal compounds
05/22/2002EP1206935A1 Th2 differentiation inhibitors
05/22/2002EP1206438A1 N-substituted norephedrine chiral derivatives, their preparation and their use for the synthesis of optically active functionalised compounds by hydrogen transfer
05/22/2002EP1206427A1 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions
05/22/2002EP0676960B1 Cycloalkyl amine bis-aryl squalene synthase inhibitors
05/21/2002US6392103 Using organometallic compound as catalyst
05/21/2002US6391915 Propanolamine derivatives
05/16/2002WO2002038534A2 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases
05/16/2002WO2002038533A1 Novel coupling components for oxidation dyes
05/16/2002WO2002006380A3 Anti-microbial polymers and composition containing same
05/16/2002WO2001049654A3 Substituted aminomethyl-phenyl-cyclohexane derivatives
05/16/2002US20020058842 Continuous hydrogenation of nitrites to primary amines in the liquid phase over a suspended, activated Raney catalyst based on an alloy of aluminum and at least one transition metal, in absence of ammonia
05/16/2002DE10056008A1 Neue Kupplerkomponenten für Oxidationsfärbemittel New coupler components for oxidation dyes
05/16/2002CA2428266A1 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases
05/15/2002EP1205528A1 Organic electroluminescent element and luminescent apparatus employing the same
05/14/2002US6388134 Chemical intermediates
05/14/2002US6387872 Detergent composition comprising alkoxylated amines
05/10/2002WO2002036542A1 Crystalline forms of venlafaxine hydrochloride
05/09/2002US20020055643 Tubulin binding ligands and corresponding prodrug constructs
05/08/2002EP1203762A2 Cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing methods
05/08/2002EP1203761A2 Calcium receptor-active compounds
05/08/2002EP1202953A2 Substituted 2-dialkylaminoalkylbiphenyl derivatives
05/08/2002CN1084328C Aryloxyane amine compounds, its prepn. and application
05/08/2002CN1084327C Process for producing amino-phenol
05/07/2002US6384281 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors
05/07/2002US6384280 Process for the preparation of polyalkylphenoxyaminoalkanes
05/02/2002WO2002034247A2 Anticancer agents based on regulation of protein prenylation
05/02/2002WO2002000609A3 2,6,7-substituted tetralines useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity
05/02/2002WO2001062082A3 Use of phenylethylamine derivatives for the anitmicrobial treatment of surfaces
05/02/2002US20020052511 Process for the preparation of matrix metalloproteinase inhibitors
05/02/2002US20020052395 Treatment or prevention of a disorder in which the regulation of monoamine transporter function is implicated, such as premature ejaculation.
05/02/2002EP1201648A1 Carbamate derivatives and agricultural/horticultural bactericides
05/02/2002EP0615448B1 Sex steroid activity inhibitors
05/02/2002DE10049483A1 Substituierte 1-Aminobutan-3-ol-Derivate Substituted 1-aminobutan-3-ol derivatives
05/02/2002DE10049481A1 Substituierte C-Cyclohexylmethylamin-Derivate C-substituted derivatives cyclohexylmethylamine
05/02/2002CA2426203A1 Anticancer agents based on regulation of protein prenylation
05/01/2002CN1083829C Synthesis of optically active aminoindanol
04/2002
04/30/2002US6380249 HIV integrase inhibitors
04/30/2002US6380149 Using mono-, di-, or trialkoxy-substituted perfluoroalkane, perfluorocycloalkane, and perfluorocycloalkyl(ene)-containing perfluoroalkane, optionally with catenary heteroatoms, and a cosolvent; good solvency, ozone depletion potential of zero
04/25/2002US20020049354 Reaction product prepared by the Mannich reaction of phenolic compounds, formaldehyde, and amine compounds; use in petrochemical plants or oil refineries
04/25/2002US20020049353 Synthetic precursors to 4-(P-methoxyphenyl)-2-amino-butane
04/25/2002US20020049328 Such as (R)-1-Cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxyl ic acid methanesulfonate; chemical intermediates; bactericides; catalysis
04/25/2002US20020049288 Metal-ligand complex precursor composition of an amine containing ligand of given formula and group 3,4, or lanthanide metal compound; polymerizing alpha-olefins, higher comonomer content of C4+ olefins
04/24/2002EP1198450A1 Alkoxylated amines
04/24/2002CN1346343A 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors
04/23/2002US6376711 Oxidation cinnamyl alcohol forming epoxide; reacting with phenol; silylating; reacting with ammonia
04/23/2002US6376707 Crystal polymorphism of aminoethylphenoxyacetic acid derivative
04/23/2002US6376524 Triphenyl compounds as interleukin-4 antagonists
04/18/2002WO2002030915A2 Aryl-indane compounds for use as inhibitors of p-glycoprotein mediated transport
04/18/2002WO2002030870A2 Substituted c-cyclohexylmethylamine derivatives
04/18/2002WO2002012166A3 Triamine derivative melanocortin receptor ligands and methods of using same
04/18/2002WO2002006207A3 Novel coupling components for oxidation colouring agents
04/18/2002US20020045724 Water-souluble polyurthane having comb-shaped hydrophobic group and application thereof
04/18/2002CA2423935A1 Substituted c-cyclohexylmethylamine derivatives
04/17/2002EP1196373A1 3-amino-2-benzyl-1-phenyl-propane derivatives
04/17/2002EP1196372A1 Quaternary nitrogen compound, fabric care composition containing same, and process for forming same
04/17/2002EP0888270B1 Dihalopropene compounds, their use as insecticides/acaricides and intermediates for their production
04/17/2002CN1345301A Improved compounds for protein binding
04/17/2002CN1082993C Photo-cross-linkable optical active smectic liquid crystal compound
04/16/2002US6372800 Immunosuppressive effect and is useful as an inhibitor for the rejection reaction occurring in organ or bone marrow transplantation, and as a preventive or remedy for articular rheumatism, atopic eczema (dermatitis), behcet's disease,
04/16/2002US6372000 Hydrocarbyl polyoxyalkylene aminoalcohol and fuel composition containing same
04/16/2002CA2061665C Treatment of lower urinary tract disorders
04/11/2002WO2002030159A1 Organic electroluminescent devices
04/11/2002WO2002028817A1 Substituted 1-aminobutan-3-ol derivatives
04/11/2002WO2002028816A1 Substituted 5-amino-1-pentene-3-ol derivatives
04/11/2002WO2002028815A1 Pharmaceutical compounds
04/11/2002WO2001044161A3 Method for producing combinatorial libraries of aryl-substituted amines
04/11/2002WO2001036374A3 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
04/11/2002US20020042431 Zwitterionic tachykinin receptor antagonists
04/11/2002US20020042410 Central nervous system disorders therapy
04/11/2002DE10048714A1 5-Amino-1-penlen-3-ol-Derivate 5-amino-1-penlen-3-ol derivatives
04/11/2002CA2423860A1 Substituted 1-aminobutan-3-ol derivatives
04/11/2002CA2419777A1 Pharmaceutical compounds
04/10/2002EP1194422A1 Biaryl compounds
04/10/2002EP1194037A1 Agrochemical compositions and surfactant compounds
04/10/2002EP0937063B1 Aryloxypropanolamine derivatives, method of preparation and applications thereof
04/09/2002US6369256 Self-reducible copper(II) source reagents for chemical vapor deposition of copper metal
04/09/2002US6369067 Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
04/09/2002US6368814 Tricyclic antidepressants and metabolites thereof
04/04/2002WO2002026694A1 O-substituted 6-methyl-tramadol derivatives
04/04/2002WO2002010178A8 Adamantyl groups containing phosphane ligands, the production and use thereof in catalytical reactions
04/04/2002WO2001093653A3 Ester quaternary mixtures
04/04/2002US20020040164 For use in anxiolytic agents
04/04/2002US20020040060 2'-methyl-biphenyl-2-carboxylic acid-(3,5-bis-trifluoromethyl-benzyl)-methyl-amide, for example; treating disease related to neurokinin 1 receptor
04/04/2002US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity
04/04/2002CA2423903A1 O-substituted 6-methyltramadol derivatives
04/03/2002EP1192140A1 Substituted herbicidal phenyluracils
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 140